LAMTOR5 and cancer: For the histological grade, the strongly positive expression of HBXIP was significantly higher in Grade-3 ovarian cancers (72.5%, 37/51) than in Grade-2 (57.1%, 16/28) and Grade-1 (46.3%, 19/41) cancers.